Abstract
PURPOSE OF REVIEW: Description of recent studies evaluating growth and inhaled corticosteroids. RECENT FINDINGS: Corticosteroids are the gold standard of asthma maintenance treatment, but effects on growth remain controversial. This is a review of recent research in this area, which has focused on medications causing less adrenal suppression as well as alternative regimens for chronic illness such as asthma. SUMMARY: The use of newer corticosteroids and regimens shows short-term evidence of minimal growth effects without worsening of asthma control.